siRNA, Anti-Human SNCA, 2'-MOE(CAT#: SIRGT23320WQ-2MOE)

The product SIRGT23320WQ-2MOE is a type of small interfering RNA (siRNA) that targets SNCA gene and regulates the expression of gene. The siRNA interferes with the expression of SNCA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification 2'-O-methoxyethyl (2'-MOE)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000345.3; NM_001146054.1; NM_001146055.1; NM_007308.2
Alternative Names NACP; PARK1; PARK4; PD1
Related Diseases Alzheimer's disease
Purification HPLC
Target Gene
Gene ID 6622
Uniprot ID P37840

Related Products